These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2936201)

  • 21. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-NAME augments PAF-induced venoconstriction in isolated perfused livers of rat and guinea pig, but not mouse.
    Cui S; Shibamoto T; Zhao Z; Takano H; Kurata Y
    Prostaglandins Leukot Essent Fatty Acids; 2007 May; 76(5):277-83. PubMed ID: 17395449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver.
    Cui S; Shibamoto T; Liu W; Takano H; Kurata Y
    Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):35-45. PubMed ID: 16846785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of platelet-activating factor in reproduction: sperm function.
    Roudebush WE
    Asian J Androl; 2001 Jun; 3(2):81-5. PubMed ID: 11404790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW; Wu MS; Biftu T
    J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of platelet-activating factor in the mammalian female reproductive tract.
    Tiemann U
    Reprod Domest Anim; 2008 Dec; 43(6):647-55. PubMed ID: 18363604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.
    McManus LM; Pinckard RN; Fitzpatrick FA; O'Rourke RA; Crawford MH; Hanahan DJ
    Lab Invest; 1981 Oct; 45(4):303-7. PubMed ID: 7300244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.
    Sturk A; Schaap MC; ten Cate JW; Heymans HS; Schutgens RB; Przyrembel H; Borst P
    J Clin Invest; 1987 Feb; 79(2):344-50. PubMed ID: 3805272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion.
    Fukuoka T; Nakajima Y; Horikawa M; Aomatsu Y; Yoshimura A; Ueno M; Ko S; Nakano H
    Transplant Proc; 1993 Apr; 25(2):1809-10. PubMed ID: 8470175
    [No Abstract]   [Full Text] [Related]  

  • 30. [Platelet activating factor as a mediator of lesions of the digestive system].
    Polonskiĭ VM
    Klin Med (Mosk); 1990 Aug; 68(8):27-31. PubMed ID: 2084366
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical significance of studies of platelet activating factor (review of the literature)].
    Daĭkhin EI; Fediushkina NA; Guseĭnov AT
    Vopr Med Khim; 1989; 35(2):10-6. PubMed ID: 2662595
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of phenylarsine oxide on agonist-induced hepatic vasoconstriction and glycogenolysis.
    Steinhelper ME; Olson MS
    Biochem Pharmacol; 1988 Mar; 37(6):1167-9. PubMed ID: 2895653
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of platelet-activating factor in biological specimens.
    Burgers JA; Akkerman JW
    J Lipid Mediat; 1991; 3(3):241-7. PubMed ID: 1773027
    [No Abstract]   [Full Text] [Related]  

  • 34. [Platelet-activating factor].
    Yin M; Fang ZY
    Sheng Li Ke Xue Jin Zhan; 1989 Jul; 20(3):261-2. PubMed ID: 2692167
    [No Abstract]   [Full Text] [Related]  

  • 35. [Etiological studies of hypertension. G. APRL (antihypertensive polar renomedullary lipid)].
    Masugi F; Ogihara T; Otsuka A; Saeki S; Nagano M; Koyama Y; Kumahara Y
    Nihon Rinsho; 1984 Feb; 42(2):306-10. PubMed ID: 6716685
    [No Abstract]   [Full Text] [Related]  

  • 36. [A platelet-activating factor--a physiologically active ether lipid].
    Weber N
    Pharm Unserer Zeit; 1986 Jul; 15(4):107-12. PubMed ID: 3749211
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings of the 4th International Congress on Platelet-Activating Factor and Related Lipid Mediators. Snowbird, Utah, 22-25 September 1992.
    J Lipid Mediat Cell Signal; 1994 Jul; 10(1-2):1-195. PubMed ID: 7953076
    [No Abstract]   [Full Text] [Related]  

  • 38. This month in investigative urology: platelet activating factor: a mediator of renal pathology?
    Felsen D; Vaughan ED
    J Urol; 1990 Jul; 144(1):140. PubMed ID: 2359165
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet-activating factor and its metabolic effects.
    Evans RD; Lund P; Williamson DH
    Prostaglandins Leukot Essent Fatty Acids; 1991 Sep; 44(1):1-10. PubMed ID: 1946557
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet-activating factor: a mediator for clinicians.
    Imaizumi TA; Stafforini DM; Yamada Y; McIntyre TM; Prescott SM; Zimmerman GA
    J Intern Med; 1995 Jul; 238(1):5-20. PubMed ID: 7608647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.